Page last updated: 2024-11-07

17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol: metabolite of norethynodrel [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID134799
CHEBI ID34186
SCHEMBL ID3500976
MeSH IDM0042484

Synonyms (26)

Synonym
unii-21t2v97q32
21t2v97q32 ,
19-nor-17alpha-pregn-5(10)-en-20-yne-3alpha,17-diol
19-norpregn-5(10)-en-20-yne-3,17-diol, (3-alpha,17-alpha)-
17alpha-ethynyl-estr-5(10)-ene-3alpha,17beta-diol
19-norpregn-5(10)-en-20-yne-3,17-diol, (3alpha,17alpha)-
nsc 77061
3alpha-hydroxynorethynodrel
19-nor-17alpha-pregn-5(10)-en-20-yne-3alpha-17beta-diol
19-nor-17-alpha-pregn-5(10)-en-20-yne-3-alpha,17-diol
17-alpha-ethynyl-estr-5(10)-ene-3-alpha,17-beta-diol
3-alpha-hydroxynorethynodrel
3.alpha.-hydroxynorethynodrel
19-nor-17.alpha.-pregn-5(10)-en-20-yne-3.alpha.,17-diol
21466-08-0
nsc-77061
17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol
19-nor-17alpha-pregn-5(10)-en-20-yne-3alpha,17beta-diol
17.alpha.-ethynylestrynylestr-5(10)-ene-3.alpha.,17.beta.-diol
17.alpha.-ethynyl-3.alpha.,17.beta.-dihydroxyestr-5(10)-ene
3.alpha.,17.beta.-dihydroxy-17.alpha.-ethynyl-.delta.5(10)-estrene
17.alpha.-ethynylestr-5(10)-ene-3.alpha.,17.beta.-diol
19-norpregn-5(10)-en-20-yne-3,17-diol, (3.alpha.,17.alpha.)-
SCHEMBL3500976
CHEBI:34186
Q27115885
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
17-hydroxy steroidA hydroxy steroid carrying a hydroxy group at position 17.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's14 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.58 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]